PMEL Recombinant Protein (Human) (OPCA02791) from Aviva Systems Biology

Description

Plays a central role in the biogenesis of melanosomes. Involved in the maturation of melanosomes from stage I to II. The transition from stage I melanosomes to stage II melanosomes involves an elongation of the vesicle, and the appearance within of distinct fibrillar structures. Release of the soluble form, ME20-S, could protect tumor cells from antibody mediated immunity

Product Specs
ItemPMEL Recombinant Protein (Human) (OPCA02791)
CompanyAviva Systems Biology
Price Supplier Page View Company Product Page
Catalog NumberOPCA02791
FormatIf the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0., Liquid or Lyophilized powder
PurityGreater than 90% as determined by SDS-PAGE
Gene Namepremelanosome protein
Molecular Weight49 kDa
NCBI Gene AliasesP1, SILV, ME20, PMEL17, gp100, ME20M, P100, SI, ME20-M, D12S53E, HMB45, HMB-45, SIL
Conjugate/TagN-terminal 6xHis-tagged
Source/Expression SystemHuman
SpeciesHomo sapiens, Human
Molecule NameMelanocyte protein PMEL
TypeProtein
Size25ul, 100ul

Sequence

KVPRNQDWLG VSRQLRTKAW NRQLYPEWTE AQRLDCWRGG QVSLKVSNDG PTLIGANASF SIALNFPGSQ KVLPDGQVIW VNNTIINGSQ VWGGQPVYPQ ETDDACIFPD GGPCPSGSWS QKRSFVYVWK TWGQYWQVLG GPVSGLSIGT GRAMLGTHTM EVTVYHRRGS RSYVPLAHSS SAFTITDQVP FSVSVSQLRA LDGGNKHFLR NQPLTFALQL HDPSGYLAEA DLSYTWDFGD SSGTLISRAL VVTHTYLEPG PVTAQVVLQA AIPLTSCGSS PVPGTTDGHR PTAEAPNTTA GQVPTTEVVG TTPGQAPTAE PSGTTSVQVP TTEVISTAPV QMPTAESTGM TPEKVPVSEV MGTTLAEMST PEATGMTPAE VSIVVLSGTT AAQVTTTEWV ETTARELPIP EPEGPDASSI MSTESITGSL GPLLDGTATL RLV

Add to Compare List